These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 3794764

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Renal function and hemodynamic studies in low- and normal-renin essential hypertension.
    Bauer JH, Brooks CS, Burch RN.
    Arch Intern Med; 1982 Jul; 142(7):1317-23. PubMed ID: 7046671
    [Abstract] [Full Text] [Related]

  • 3. Renal hemodynamics in hypertensive renal allograft recipients: effects of calcium antagonists and ACE inhibitors.
    Grekas D, Dioudis C, Kalevrosoglou I, Alivanis P, Derveniotis V, Tourkantonis A.
    Kidney Int Suppl; 1996 Jun; 55():S97-100. PubMed ID: 8743523
    [Abstract] [Full Text] [Related]

  • 4. Effect of short-term and long-term treatment with metoprolol on renal blood flow and glomerular filtration rate in hypertensive patients with a normal kidney function.
    Strandgaard S, Elmgreen J, Christensen TE, Laursen SW.
    Dan Med Bull; 1982 Oct; 29(6):287-9. PubMed ID: 7140383
    [No Abstract] [Full Text] [Related]

  • 5. [Correlation of renin-angiotensin system and prostanoids system in renal circulation: dissociation of renal blood flow and glomerular filtration rate in acute alterations of renal blood pressure].
    Goto F.
    Masui; 1984 Nov; 33(11):1204-12. PubMed ID: 6394780
    [No Abstract] [Full Text] [Related]

  • 6. Beta-blockers and the kidney.
    Epstein M, Oster JR.
    Miner Electrolyte Metab; 1982 Nov; 8(5):237-54. PubMed ID: 6132329
    [No Abstract] [Full Text] [Related]

  • 7. The influence of verapamil on renal function in patients treated with cisplatin.
    Offerman JJ, Meijer S, Sleijfer DT, Mulder NH, Donker AJ, Schraffordt Koops H, van der Hem GK.
    Clin Nephrol; 1985 Nov; 24(5):249-55. PubMed ID: 2416501
    [Abstract] [Full Text] [Related]

  • 8. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P, Volpin R, Piovan D, Bortoluzzi A, Craighero R, Bottaro S, Finucci GF, Casiglia E, Sticca A, De Toni R, Pavan L, Gatta A.
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [Abstract] [Full Text] [Related]

  • 9. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
    Semplicini A, Ceolotto G, Sartori M, Maresca A, Baritono E, De Toni R, Paparella I, Calò L.
    J Nephrol; 2002 Oct; 15(5):489-96. PubMed ID: 12455714
    [Abstract] [Full Text] [Related]

  • 10. Acute effects of calcitonin gene related peptide on renal haemodynamics and renin and angiotensin II secretion in patients with renal disease.
    Palla R, Parrini M, Panichi V, Andreini B, De Pietro S, Migliori M, Bianchi AM, Giovannini L, Bertelli A, Bertelli AA.
    Int J Tissue React; 1995 Oct; 17(1):43-9. PubMed ID: 7499063
    [Abstract] [Full Text] [Related]

  • 11. [The effect of verapamil on cardio- and hemodynamics in rats with various models of hypertension].
    Spasov AA, Gurbanov KG, Seredintseva NV, Paperno AA.
    Eksp Klin Farmakol; 1997 Oct; 60(3):30-3. PubMed ID: 9324394
    [Abstract] [Full Text] [Related]

  • 12. Effect of light exercise on renal hemodynamics in patients with hypertension and chronic renal disease.
    Svarstad E, Myking O, Ofstad J, Iversen BM.
    Scand J Urol Nephrol; 2002 Oct; 36(6):464-72. PubMed ID: 12623513
    [Abstract] [Full Text] [Related]

  • 13. [Prestarium treatment of essential hypertension].
    Kakhnovskiĭ IM, Sivkov SI, Gavrilova EN, Belaia OL, Sivkov AS, Markova ZS, Markov IE, Gaĭdamakina NE.
    Klin Med (Mosk); 1998 Oct; 76(9):52-4. PubMed ID: 9821376
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin II as a risk factor for cyclosporin nephrotoxicity in patients with psoriasis.
    Edwards BD, Chalmers RJ, O'Driscoll JB, Mitchell DM, Smith RJ, Lawson RS, Testa HJ, Ballardie FW.
    Clin Nephrol; 1994 Jun; 41(6):350-6. PubMed ID: 8076438
    [Abstract] [Full Text] [Related]

  • 15. Contrasting effects of the renin-angiotensin system on renal function disclosed during converting enzyme inhibition in patients with renal hypertension.
    Rasmussen S, Ibsen H, Giese J.
    Scand J Urol Nephrol Suppl; 1984 Jun; 79():49-52. PubMed ID: 6089319
    [Abstract] [Full Text] [Related]

  • 16. [Ednit effects on activity of renin-angiotensin-aldosterone system and renal function in hypertensive subjects with diabetes mellitus].
    Zonis BIa, Volkova NI, Sokolov OIu.
    Ter Arkh; 2000 Jun; 72(2):53-5. PubMed ID: 10717928
    [Abstract] [Full Text] [Related]

  • 17. The angiotensin converting enzyme inhibitor enalapril and its effects on renal function.
    de Zeeuw D, Navis GJ, Donker AJ, de Jong PE.
    J Hypertens Suppl; 1983 Oct; 1(1):93-7. PubMed ID: 6100614
    [Abstract] [Full Text] [Related]

  • 18. Comparative effects of antihypertensive therapy with guanabenz and propranolol on renal vascular resistance and left ventricular mass.
    Mosley C, O'Connor DT, Taylor A, Slutsky RA, Cervenka J.
    J Cardiovasc Pharmacol; 1984 Oct; 6 Suppl 5():S757-61. PubMed ID: 6084120
    [Abstract] [Full Text] [Related]

  • 19. Effects of the PPAR-gamma agonist rosiglitazone on renal haemodynamics and the renin-angiotensin system in diabetes.
    Lansang MC, Coletti C, Ahmed S, Gordon MS, Hollenberg NK.
    J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):175-80. PubMed ID: 17094055
    [Abstract] [Full Text] [Related]

  • 20. [Changes in central hemodynamics and renal blood flow after correction of arterial hypertension with diltiazem].
    Ivleva AIa, Gavrilova EN, Krasnobaeva GM, Shatkovskiĭ NP, Gaĭdamakina NE.
    Sov Med; 1989 Sep; (5):70-3. PubMed ID: 2675337
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.